This is a dose escalation, pilot study for subjects with sickle cell anemia (SCA) disease to determine if metformin has a beneficial effect on the treatment and quality of life of SCA patients.
The purpose of this study is to determine whether metformin is effective in the treatment for sickle cell anemia (SCA).